Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2158851rdf:typepubmed:Citationlld:pubmed
pubmed-article:2158851lifeskim:mentionsumls-concept:C0003459lld:lifeskim
pubmed-article:2158851lifeskim:mentionsumls-concept:C0027747lld:lifeskim
pubmed-article:2158851lifeskim:mentionsumls-concept:C0501384lld:lifeskim
pubmed-article:2158851lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:2158851lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:2158851pubmed:issue2lld:pubmed
pubmed-article:2158851pubmed:dateCreated1990-6-4lld:pubmed
pubmed-article:2158851pubmed:abstractTextAt frog neuromuscular junctions immersed in solutions containing 0.5 mM Mn2+, verapamil (40 microM) reduced the increase in miniature end-plate potential (MEPP) frequency produced by tetanic stimulation (50 Hz, 2 min) of the motor nerve to 5% of that in the absence of verapamil. In solutions containing 5 mM Mg2+, verapamil reduced the tetanic increase in MEPP frequency to 8% of that in the absence of verapamil. Verapamil added to solutions containing 0.15 mM Ca2+ decreased the tetanic rise in MEPP frequency to 6% of the control value. In low Ca2+ (nominally Ca2(+)-free) solutions, verapamil decreased the tetanic rise to 70% of the control value. The present results suggest that Mn2+ and Mg2+, as well as Ca2+, enter the nerve terminal through Ca2+ channels during nerve stimulation and promote transmitter release. In addition to its effect on the Ca2+ channel, verapamil at higher concentrations appears to have inhibitory effects on the acetylcholine-gated end-plate channel and on the Na+ channel as suggested by its depressive effects on the amplitudes of MEPPs, end-plate potentials and nerve terminal action potentials.lld:pubmed
pubmed-article:2158851pubmed:languageenglld:pubmed
pubmed-article:2158851pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158851pubmed:citationSubsetIMlld:pubmed
pubmed-article:2158851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158851pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158851pubmed:statusMEDLINElld:pubmed
pubmed-article:2158851pubmed:monthMarlld:pubmed
pubmed-article:2158851pubmed:issn0006-8993lld:pubmed
pubmed-article:2158851pubmed:authorpubmed-author:KitaHHlld:pubmed
pubmed-article:2158851pubmed:authorpubmed-author:NaritaKKlld:pubmed
pubmed-article:2158851pubmed:authorpubmed-author:KawasakiFFlld:pubmed
pubmed-article:2158851pubmed:issnTypePrintlld:pubmed
pubmed-article:2158851pubmed:day5lld:pubmed
pubmed-article:2158851pubmed:volume510lld:pubmed
pubmed-article:2158851pubmed:ownerNLMlld:pubmed
pubmed-article:2158851pubmed:authorsCompleteYlld:pubmed
pubmed-article:2158851pubmed:pagination289-95lld:pubmed
pubmed-article:2158851pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:meshHeadingpubmed-meshheading:2158851-...lld:pubmed
pubmed-article:2158851pubmed:year1990lld:pubmed
pubmed-article:2158851pubmed:articleTitleMn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs.lld:pubmed
pubmed-article:2158851pubmed:affiliationDepartment of Physiology, Kawasaki Medical School, Okayama, Japan.lld:pubmed
pubmed-article:2158851pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2158851pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2158851pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2158851lld:pubmed